TrialAnnals of oncology : official journal of the European Society for Medical Oncology2018

Immunotherapeutic maintenance treatment with toll-like receptor 9 agonist lefitolimod in patients with extensive-stage small-cell lung cancer: results from the exploratory, controlled, randomized, international phase II IMPULSE study.

M Thomas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.